| RRC ID |
74560
|
| 著者 |
Ando H, Ikeda A, Tagami M, Matsuo NCA, Shimizu T, Ishima Y, Eshima K, Ishida T.
|
| タイトル |
Oral administration of sodium bicarbonate can enhance the therapeutic outcome of Doxil® via neutralizing the acidic tumor microenvironment.
|
| ジャーナル |
J Control Release
|
| Abstract |
The pH of the tumor microenvironment in solid tumors is reported to be more acidic than that of normal tissues. The pH is controlled by over-expression of several transporters that are associated with the progression, angiogenesis, and metastasis of solid tumors. Antitumor effects of weak-base anticancer agents, such as doxorubicin (DXR), could be reduced in an acidic environment because of increases in the ionized form of the drug under these conditions, reducing its membrane penetrability. In our previous studies, we demonstrated that oral administration of sodium bicarbonate (NaHCO3) can neutralize the acidic tumor microenvironment and enhance the effects of small molecule anticancer drugs. However, it is not known whether or not increasing the tumor pH by oral administration of NaHCO3 leads to enhanced antitumor effects of lipidic nanoparticle formulations of weak-base anticancer drugs, such as Doxil®. In this study, we investigated the antitumor efficacy of Doxil® in combination with oral administration of NaHCO3 in a Colon26 tumor-bearing mouse model. NaHCO3 clearly enhanced the tumor-growth inhibitory effect of Doxil® without exacerbating any systemic side effects. In vitro studies indicated that high levels of DXR were internalized into cells at neutral pH. These studies demonstrate that the neutralization of acidic tumor microenvironment by an oral administration of NaHCO3 could be a promising approach to enhance the therapeutic outcomes of Doxil®.
|
| 巻・号 |
350
|
| ページ |
414-420
|
| 公開日 |
2022-10-1
|
| DOI |
10.1016/j.jconrel.2022.08.031
|
| PII |
S0168-3659(22)00536-3
|
| PMID |
35988781
|
| MeSH |
Acids
Administration, Oral
Animals
Antineoplastic Agents*
Doxorubicin / analogs & derivatives
Mice
Neoplasms* / drug therapy
Polyethylene Glycols
Sodium Bicarbonate / therapeutic use
Treatment Outcome
Tumor Microenvironment
|
| IF |
7.727
|
| リソース情報 |
| ヒト・動物細胞 |
Colon-26(RCB2657) |
